Next-Generation Sequencing in Pharmacogenomics: Opportunities for Personalized Drug Therapy

Pharmacogenomics (PGx) is revolutionizing the field of personalized medicine by leveraging individuals' genetic profiles to tailor drug therapy according to their unique genetic makeup. In recent years, next-generation sequencing (NGS) has emerged as a game-changing technology in pharmacogenomics research, enabling comprehensive analysis of genes involved in drug metabolism and providing valuable insights for personalized drug therapy.
Sequencing in Pharmacogenomics technologies have advanced rapidly, allowing researchers and clinicians to study the genomic variations that impact drug response and efficacy. NGS platforms offer high-throughput sequencing capabilities, enabling the simultaneous analysis of a large number of genes or even the entire genome, which was previously time-consuming and expensive with traditional methods. This breakthrough has opened up new possibilities in pharmacogenomics, paving the way for more targeted and e...